Skip to main content
. 2013 Oct 8;8(10):e71924. doi: 10.1371/journal.pone.0071924

Table 3. Risk Factors Associated with Late Mortality Compared to Survival in Patients with IPD in Calgary.

Risk Factor Risk Factor Sub-category RRR Late Mortality to Survival (95% CI)a P-value
Disease Severity Modified by Comorbidities Less severe disease and Charlson comorbidity index =0 Reference group
More severe disease and Charlson comorbidity index=0 21.1 (4.2-105.7) <0.001
Less severe disease and Charlson comorbidity index=1 -b -a
More severe disease and Charlson comorbidity index =1 22.6 (4.5-113.9) <0.001
Less severe disease and Charlson comorbidity index ≥2 6.1 (1.4-27.7) 0.018
More severe disease and Charlson comorbidity index ≥2 22.4 (4.8-103.9) <0.001
Age Per 5 year increase 1.3 (1.1-1.4) <0.001
Gender Female Reference group
Male 0.6 (0.3-1.2) 0.163
Primary Diagnosis Bacteremia/other invasive diagnosis Reference group
Pneumonia/empyema diagnosis 1.0 (0.3-3.1) 0.990
Meningitis 3.3 (0.8-14.1) 0.099
Time to receipt of appropriate antibiotic treatment <24 hours post-presentation Reference group
24-48 hours post-presentation 1.2 (0.3-4.3) 0.776
>48 hours post-presentation 1.6 (0.4-6.1) 0.463
No receipt of appropriate antibiotics 0.8 (0.1-6.7) 0.863

a RRR=Relative Risk Ratio 95% CI = 95% Confidence Interval; b. No inferences can be made with this estimate due to a zero cell.